Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Thermo Fisher Scientific Inc Announces Pricing Of $2.2 Billion Common Stock Offering


Friday, 7 Jun 2013 06:00am EDT 

Thermo Fisher Scientific Inc announced that it has priced an underwritten public offering of 25,730,994 shares of common stock at $85.50 per share in connection with the forward sale agreements described below. J.P. Morgan and Barclays are acting as joint book-running managers and as representatives of the underwriters for the offering. BofA Merrill Lynch is acting as book-running manager for the offering. Thermo Fisher intends to use any net proceeds it receives upon the future settlement of the forward sale agreements, or upon any issuance and sale to the underwriters of common stock in the offering, to fund a portion of previously announced acquisition of Life Technologies Corporation (Life Technologies). In connection with the offering of common stock, Thermo Fisher entered into forward sale agreements with affiliates of each of J.P. Morgan and Barclays, which affiliates are referred to as the forward counterparties. The forward counterparties (or their respective affiliates) are expected to borrow from third parties and sell to the public through the underwriters up to 25,730,994 shares of Thermo Fisher`s common stock (assuming no exercise by the underwriters of their over-allotment option described below). 

Company Quote

127.67
0.88 +0.69%
26 Dec 2014